Schizophrenia.com
REXULTI (brexpiprazole): Approved as Adjunctive Therapy to Treat Adults with MDD and Schizophrenia
Medications
everhopeful
July 20, 2023, 11:35pm
1
Related topics
Topic
Replies
Views
Activity
Rexulti Approval Expanded to Include Adolescents With Schizophrenia
News
0
224
December 29, 2021
Rexulti - theraputic dose
Medications
6
1637
July 24, 2015
FDA Approves Otsuka and Lundbeck’s REXULTI (Brexpiprazole)
News
9
4448
July 13, 2015
FDA accepts supplemental new drug application for Rexulti
Medications
1
306
October 15, 2021
Health Canada Approves Otsuka and Lundbeck's REXULTI™ (brexpiprazole) as a Treatment for Schizophrenia in Adults
News
0
600
February 18, 2017